Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows.

Europe: Five largest Private Equity/Venture Financing deals by value in the Pharmaceuticals sector (LTM June 2022)

  • A total of 262 Private Equity/Venture Financing deals (pending and completed) were announced in the Pharmaceuticals of the Europe region, in the last twelve months resulting in a total deal value of over $18,343.9 million. In the LTM period, September 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $8,839.6 million, resulting in an average deal value of $401.8 million during that month. On the other hand, the month of February 2022 was the most prolific in terms of deal volume, recording a total of 30 deals, resulting in an average deal value of $30.8 million during that month.

  • Of the 262 deals, the deal secured between Advent International Corp; Agnafit Bidco AB; Aurora Investment Pte Ltd; GIC Pte Ltd and Swedish Orphan Biovitrum AB, was the largest Private Equity/Venture Financing deal in the Europe Pharmaceuticals sector, which was valued at $8,047.6 million and was completed on September 2, 2021. The second-largest deal was between Partners Group AG and Pharmathen S.A., while the third-largest deal was between Epidarex Capital III UK; Scottish Enterprise and Kynos Therapeutics Ltd. The Partners Group AG-Pharmathen S.A. deal and the Epidarex Capital III UK; Scottish Enterprise-Kynos Therapeutics Ltd deal were valued at $1,888.7 million and $506.6 million, respectively. The fourth-largest deal was between Blackstone Life Sciences Advisors LLC-Sanofi valued at $328.3 million, whereas the deal between PPF Group NV-SOTIO Biotech AG valued at $317.1 million was the fifth-largest deal.

  • Cumulatively, the top five deals amounted to $11,088.4 million and accounted for nearly 60.45% of the total deals (by value) announced during the last twelve months. The Europe region accounted for 22.81% of the total Private Equity/Venture Financing deals done globally, and accounted for 3.52% of the total deal size on a global scale.

Europe: Five largest Private Equity/Venture Financing deals by value in the Pharmaceuticals sector (LTM June 2022)

Published: June 2022
Source: GlobalData

Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Visit Report Store
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward